The mechanisms regulating cyclin-dependent kinase 5 in hippocampus during systemic inflammatory response: The effect on inflammatory gene expression

Neurochemistry International

Volumn 93, Issue , 2016, Pages 103-112

  Czapski, Grzegorz A ^a   Gassowska, Magdalena ^a   Wilkaniec, Anna ^a   Chalimoniuk, Małgorzata ^a   Strosznajder, Joanna B ^a   Adamczyk, Agata ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Cyclin dependent kinase 5; Hippocampus; Lipopolysaccharide; Neuroinflammation; Systemic inflammation

Indexed keywords

CALPAIN; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3BETA; LIPOPOLYSACCHARIDE; PROTEIN P25; PROTEIN P35; CDK5 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMICAL ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETICS; HIPPOCAMPUS; HYPERACTIVITY; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; C57BL MOUSE; ENZYMOLOGY; METABOLISM;

ANIMALS; CYCLIN-DEPENDENT KINASE 5; GENE EXPRESSION; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84958863605     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2016.01.005     Document Type: Article

References (70)

1. A. Arif Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5 Biochem. Pharmacol. 84 2012 985 993
2. A. Arif, J. Jia, R.A. Moodt, P.E. DiCorleto, and P.L. Fox Phosphorylation of glutamyl-prolyl tRNA synthetase by cyclin-dependent kinase 5 dictates transcript-selective translational control Proc. Natl. Acad. Sci. U. S. A. 108 2011 1415 1420
3. N. Berberich, B. Uhl, J. Joore, U.K. Schmerwitz, B.A. Mayer, C.A. Reichel, F. Krombach, S. Zahler, A.M. Vollmar, and R. Furst Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9 Br. J. Pharmacol. 163 2011 1086 1098
4. K. Bhaskar, M. Konerth, O.N. Kokiko-Cochran, A. Cardona, R.M. Ransohoff, and B.T. Lamb Regulation of tau pathology by the microglial fractalkine receptor Neuron 68 2010 19 31
5. B.K. Binukumar, Y.L. Zheng, V. Shukla, N.D. Amin, P. Grant, and H.C. Pant TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity J. Alzheimer's Dis. 39 2014 899 909
6. G. Brooks Cyclin-dependent kinases and cyclin-dependent kinase inhibitors. Detection methods and activity measurements Methods Mol. Biol. 124 2001 161 170
7. J.F. Castro-Alvarez, A. Uribe-Arias, and G.P. Cardona-Gomez Cyclin-Dependent kinase 5 targeting prevents beta-Amyloid aggregation involving glycogen synthase kinase 3beta and phosphatases J. Neurosci. Res. 93 2015 1258 1266
8. L. Chagniel, C. Robitaille, M. Lebel, and M. Cyr Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model Neurobiol. Dis. 45 2012 645 655
9. L. Crews, C. Patrick, A. Adame, E. Rockenstein, and E. Masliah Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease Cell Death Dis. 2 2011 e120
10. G.A. Czapski, A. Adamczyk, R.P. Strosznajder, and J.B. Strosznajder Expression and activity of PARP family members in the hippocampus during systemic inflammation: their role in the regulation of prooxidative genes Neurochem. Int. 62 2013 664 673
11. G.A. Czapski, M. Cakala, M. Chalimoniuk, B. Gajkowska, and J.B. Strosznajder Role of nitric oxide in the brain during lipopolysaccharide-evoked systemic inflammation J. Neurosci. Res. 85 2007 1694 1703
12. G.A. Czapski, M. Cakala, B. Gajkowska, and J.B. Strosznajder Poly(ADP-ribose) polymerase-1 inhibition protects the brain against systemic inflammation Neurochem. Int. 49 2006 751 755
13. G.A. Czapski, M. Cakala, D. Kopczuk, M. Kaminska, and J.B. Strosznajder Inhibition of nitric oxide synthase prevents energy failure and oxidative damage evoked in the brain by lipopolysaccharide Pol. J. Pharmacol. 56 2004 643 646
14. G.A. Czapski, B. Gajkowska, and J.B. Strosznajder Systemic administration of lipopolysaccharide induces molecular and morphological alterations in the hippocampus Brain Res. 1356 2010 85 94
15. G.A. Czapski, M. Gassowska, M. Songin, U.D. Radecka, and J.B. Strosznajder Alterations of cyclin dependent kinase 5 expression and phosphorylation in amyloid precursor protein (APP)-transfected PC12 cells FEBS Lett. 585 2011 1243 1248
16. G.A. Czapski, M. Gassowska, A. Wilkaniec, M. Cieslik, and A. Adamczyk Extracellular alpha-synuclein induces calpain-dependent overactivation of cyclin-dependent kinase 5 in vitro FEBS Lett. 587 2013 3135 3141
17. Y. Ding, A. Qiao, Z. Wang, J.S. Goodwin, E.S. Lee, M.L. Block, M. Allsbrook, M.P. McDonald, and G.H. Fan Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model J. Neurosci. 28 2008 11622 11634
18. J. Du, N. Wei, T. Guan, H. Xu, J. An, K.A. Pritchard Jr., and Y. Shi Inhibition of CDKS by roscovitine suppressed LPS-induced∗NO production through inhibiting NFkappaB activation and BH4 biosynthesis in macrophages Am. J. Physiol. Cell Physiol. 297 2009 C742 C749
19. M. Erta, A. Quintana, and J. Hidalgo Interleukin-6, a major cytokine in the central nervous system Int. J. Biol. Sci. 8 2012 1254 1266
20. D.B. Evans, K.B. Rank, K. Bhattacharya, D.R. Thomsen, M.E. Gurney, and S.K. Sharma Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly J. Biol. Chem. 275 2000 24977 24983
21. T. Harada, T. Morooka, S. Ogawa, and E. Nishida ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1 Nat. Cell Biol. 3 2001 453 459
22. M. Hassan, H. Sallam, and Z. Hassan The role of pharmacokinetics and pharmacodynamics in early drug development with reference to the cyclin-dependent kinase (Cdk) inhibitor - roscovitine Sultan Qaboos Univ. Med. J. 11 2011 165 178
23. S.-I. Hisanaga, and K. Ishiguro The kinase activity of Cdk5 and its regulation I. NY, T. L-H, Cyclin Dependent Kinase 5 (Cdk5) 2008 Springer Science +Business Media LLC New York
24. M. Jacewicz, G.A. Czapski, I. Katkowska, and R.P. Strosznajder Systemic administration of lipopolysaccharide impairs glutathione redox state and object recognition in male mice. The effect of PARP-1 inhibitor Folia Neuropathol. 47 2009 321 328
25. R.S. Jhou, K.H. Sun, G.H. Sun, H.H. Wang, C.I. Chang, H.C. Huang, S.Y. Lu, and S.J. Tang Inhibition of cyclin-dependent kinases by olomoucine and roscovitine reduces lipopolysaccharide-induced inflammatory responses via down-regulation of nuclear factor kappaB Cell Prolif. 42 2009 141 149
26. S.V. Kabadi, and A.I. Faden Selective CDK inhibitors: promising candidates for future clinical traumatic brain injury trials Neural. Regen. Res. 9 2014 1578 1580
27. S.V. Kabadi, B.A. Stoica, K.R. Byrnes, M. Hanscom, D.J. Loane, and A.I. Faden Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma J. Cereb. Blood Flow Metabol. 32 2012 137 149
28. J. Kanungo, Y.L. Zheng, N.D. Amin, and H.C. Pant Targeting Cdk5 activity in neuronal degeneration and regeneration Cell. Mol. Neurobiol. 29 2009 1073 1080
29. T. Kimura, K. Ishiguro, and S. Hisanaga Physiological and pathological phosphorylation of tau by Cdk5 Front. Mol. Neurosci. 7 2014 65
30. M. Kitazawa, K.N. Green, A. Caccamo, and F.M. LaFerla Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice Am. J. Pathol. 168 2006 1986 1997
31. M. Kitazawa, S. Oddo, T.R. Yamasaki, K.N. Green, and F.M. LaFerla Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease J. Neurosci. 25 2005 8843 8853
32. G. Kusakawa, T. Saito, R. Onuki, K. Ishiguro, T. Kishimoto, and S. Hisanaga Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25 J. Biol. Chem. 275 2000 17166 17172
33. D.C. Lee, J. Rizer, M.L. Selenica, P. Reid, C. Kraft, A. Johnson, L. Blair, M.N. Gordon, C.A. Dickey, and D. Morgan LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice J. Neuroinflam. 7 2010 56
34. J. Lee, N. Yun, C. Kim, M.Y. Song, K.S. Park, and Y.J. Oh Acetylation of cyclin-dependent kinase 5 is mediated by GCN5 Biochem. Biophys. Res. Commun. 447 2014 121 127
35. K.Y. Lee, L. Liu, Y. Jin, S.B. Fu, and J.L. Rosales Cdk5 mediates vimentin Ser56 phosphorylation during GTP-induced secretion by neutrophils J. Cell. Physiol. 227 2012 739 750
36. A.E. Leitch, N.A. Riley, T.A. Sheldrake, M. Festa, S. Fox, R. Duffin, C. Haslett, and A.G. Rossi The cyclin-dependent kinase inhibitor R-roscovitine down-regulates Mcl-1 to override pro-inflammatory signalling and drive neutrophil apoptosis Eur. J. Immunol. 40 2010 1127 1138
37. J.P. Lopes, and P. Agostinho Cdk5: multitasking between physiological and pathological conditions Prog. Neurobiol. 94 2011 49 63
38. J.P. Lopes, C.R. Oliveira, and P. Agostinho Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides Cell Cycle 8 2009 97 104
39. A. Lopez-Tobon, J.F. Castro-Alvarez, D. Piedrahita, R.L. Boudreau, J.C. Gallego-Gomez, and G.P. Cardona-Gomez Silencing of CDK5 as potential therapy for Alzheimer's disease Rev. Neurosci. 22 2011 143 152
40. B. Menn, S. Bach, T.L. Blevins, M. Campbell, L. Meijer, and S. Timsit Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models PLoS One 5 2010 e12117
41. O.M. Mitrasinovic, G.V. Perez, F. Zhao, Y.L. Lee, C. Poon, and G.M. Murphy Jr. Overexpression of macrophage colony-stimulating factor receptor on microglial cells induces an inflammatory response J. Biol. Chem. 276 2001 30142 30149
42. G. Morfini, G. Szebenyi, H. Brown, H.C. Pant, G. Pigino, S. DeBoer, U. Beffert, and S.T. Brady A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons EMBO J. 23 2004 2235 2245
43. R. Morigaki, W. Sako, S. Okita, J. Kasahara, H. Yokoyama, S. Nagahiro, R. Kaji, and S. Goto Cyclin-dependent kinase 5 with phosphorylation of tyrosine 15 residue is enriched in striatal matrix compartment in adult mice Neuroscience 189 2011 25 31
44. D. Muyllaert, D. Terwel, A. Kremer, K. Sennvik, P. Borghgraef, H. Devijver, I. Dewachter, and F. Van Leuven Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration Am. J. Pathol. 172 2008 470 485
45. A.L. Nikkel, B. Martino, S. Markosyan, J.D. Brederson, R. Medeiros, A. Moeller, and R.S. Bitner The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo Neuropharmacology 63 2012 606 612
46. G.N. Patrick, P. Zhou, Y.T. Kwon, P.M. Howley, and L.H. Tsai the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway p.35 J. Biol. Chem. 273 1998 24057 24064
47. G.N. Patrick, L. Zukerberg, M. Nikolic, S. de la Monte, P. Dikkes, and L.H. Tsai Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration Nature 402 1999 615 622
48. D.W. Peterson, D.M. Ando, D.A. Taketa, H. Zhou, F.W. Dahlquist, and J. Lew No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro Proc. Natl. Acad. Sci. U. S. A. 107 2010 2884 2889
49. R.Y. Poon, J. Lew, and T. Hunter Identification of functional domains in the neuronal Cdk5 activator protein J. Biol. Chem. 272 1997 5703 5708
50. J. Qu, T. Nakamura, G. Cao, E.A. Holland, S.R. McKercher, and S.A. Lipton S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide Proc. Natl. Acad. Sci. U. S. A. 108 2011 14330 14335
51. J. Qu, T. Nakamura, E.A. Holland, S.R. McKercher, and S.A. Lipton S-nitrosylation of Cdk5: potential implications in amyloid-beta-related neurotoxicity in Alzheimer disease Prion 6 2012 364 370
52. R.A. Quintanilla, D.I. Orellana, C. Gonzalez-Billault, and R.B. Maccioni Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway Exp. Cell Res. 295 2004 245 257
53. A.D. Roe, M.A. Staup, J. Serrats, P.E. Sawchenko, and R.A. Rissman Lipopolysaccharide-induced tau phosphorylation and kinase activity-modulation, but not mediation, by corticotropin-releasing factor receptors Eur. J. Neurosci. 34 2011 448 456
54. J. Rosales, B. Han, and K.Y. Lee Cdk7 functions as a cdk5 activating kinase in brain Cell. Physiology Biochem. 13 2003 285 296
55. H. Sallam, P. Jimenez, H. Song, M. Vita, A. Cedazo-Minguez, and M. Hassan Age-dependent pharmacokinetics and effect of roscovitine on Cdk5 and Erk1/2 in the rat brain Pharmacol. Res. 58 2008 32 37
56. J. Scheller, C. Garbers, and S. Rose-John Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities Sem. Immunol. 26 2014 2 12
57. A. Semmler, T. Okulla, M. Sastre, L. Dumitrescu-Ozimek, and M.T. Heneka Systemic inflammation induces apoptosis with variable vulnerability of different brain regions J. Chem. Neuroanat. 30 2005 144 157
58. P. Sharma, M. Sharma, N.D. Amin, R.W. Albers, and H.C. Pant Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation Proc. Natl. Acad. Sci. U. S. A. 96 1999 11156 11160
59. P. Sharma, M. Veeranna Sharma, N.D. Amin, R.K. Sihag, P. Grant, N. Ahn, A.B. Kulkarni, and H.C. Pant Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway J. Biol. Chem. 277 2002 528 534
60. H. Song, M. Vita, H. Sallam, R. Tehranchi, C. Nilsson, A. Siden, and Z. Hassan Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro Cancer Chemother. Pharmacol. 60 2007 841 849
61. J.R. Sundaram, E.S. Chan, C.P. Poore, T.K. Pareek, W.F. Cheong, G. Shui, N. Tang, C.M. Low, M.R. Wenk, and S. Kesavapany Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration J. Neurosci. 32 2012 1020 1034
62. S. Takahashi, T. Ohshima, M. Hirasawa, T.K. Pareek, T.H. Bugge, A. Morozov, K. Fujieda, R.O. Brady, and A.B. Kulkarni Conditional deletion of neuronal cyclin-dependent kinase 5 in developing forebrain results in microglial activation and neurodegeneration Am. J. Pathol. 176 2010 320 329
63. C. Tarricone, R. Dhavan, J. Peng, L.B. Areces, L.H. Tsai, and A. Musacchio Structure and regulation of the CDK5-p25(nck5a) complex Mol. Cell 8 2001 657 669
64. E. Utreras, A. Futatsugi, P. Rudrabhatla, J. Keller, M.J. Iadarola, H.C. Pant, and A.B. Kulkarni Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35 J. Biol. Chem. 284 2009 2275 2284
65. M. Vita, M. Abdel-Rehim, S. Olofsson, Z. Hassan, L. Meurling, A. Siden, M. Siden, T. Pettersson, and M. Hassan Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat Eur. J. Pharm. Sci. 25 2005 91 103
66. Y. Wen, E. Planel, M. Herman, H.Y. Figueroa, L. Wang, L. Liu, L.F. Lau, W.H. Yu, and K.E. Duff Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing J. Neurosci. 28 2008 2624 2632
67. Y. Yamamura, R. Morigaki, J. Kasahara, H. Yokoyama, A. Tanabe, S. Okita, H. Koizumi, S. Nagahiro, R. Kaji, and S. Goto Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice Front. Cell Neurosci. 7 2013 12
68. P. Zhang, P.C. Yu, A.H. Tsang, Y. Chen, A.K. Fu, W.Y. Fu, K.K. Chung, and N.Y. Ip S-nitrosylation of cyclin-dependent kinase 5 (cdk5) regulates its kinase activity and dendrite growth during neuronal development J. Neurosci. 30 2010 14366 14370
69. X. Zhang, H. Zhang, H. Shao, Q. Xue, and B. Yu ERK MAP kinase activation in spinal cord regulates phosphorylation of Cdk5 at serine 159 and contributes to peripheral inflammation induced pain/hypersensitivity PLoS One 9 2014 e87788
70. L.R. Zukerberg, G.N. Patrick, M. Nikolic, S. Humbert, C.L. Wu, L.M. Lanier, F.B. Gertler, M. Vidal, R.A. Van Etten, and L.H. Tsai Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth Neuron 26 2000 633 646